专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

JP2014101329A Antiinflammatory agents 有权
标题翻译：抗炎药
公开(公告)号：JP2014101329A
公开(公告)日：2014-06-05
申请号：JP2012255386
申请日：2012-11-21
申请人： Kao Corp , 花王株式会社
发明人： KUWANO TETSUYA , WATANABE MANABU , MURASE TAKATOSHI
IPC分类号： A61K31/12 , A61P29/00 , A61P43/00
摘要： PROBLEM TO BE SOLVED: To provide novel antiinflammatory agents useful as antiinflammatory agents whose inflammatory cytokine expression inhibitory action and prostaglandin production inhibitory action are sufficiently strong.SOLUTION: An antiinflammatory agent comprises a methoxychalkone represented by the specified general formula as an active ingredient. (In the formula, Rand Reach represent a hydrogen atom or a methyl group.)
摘要翻译：要解决的问题：提供可用作抗炎剂的新型抗炎剂，其抗炎症细胞因子表达抑制作用和前列腺素产生抑制作用足够强。解决方案：抗炎剂包含由指定的通式表示的甲氧基酮酮作为活性成分。（在该式中，Rand Reach表示氢原子或甲基。）

2. 发明专利

JP2013237657A PPARγ ACTIVITY INHIBITOR 审中-公开
标题翻译： PPARγ活性抑制剂
公开(公告)号：JP2013237657A
公开(公告)日：2013-11-28
申请号：JP2012113282
申请日：2012-05-17
申请人： Kao Corp , 花王株式会社
发明人： KIUCHI SATOMI , MURASE TAKATOSHI
IPC分类号： A61K31/352 , A23L1/30 , A23L1/302 , A61K8/49 , A61K8/73 , A61K8/97 , A61K31/4188 , A61K31/733 , A61K36/18 , A61P17/00 , A61P17/10 , A61P43/00 , A61Q19/00
摘要： PROBLEM TO BE SOLVED: To provide a material capable of inhibiting activation of PPARγ (Peroxisome Proliferator Activated Receptor gamma).SOLUTION: A PPARγ activity inhibitor includes as active ingredients, one or more kinds selected from a group comprising luteolin, quercetin, perilla or its extract, biotin and inulin.
摘要翻译：要解决的问题：提供能够抑制PPARγ（过氧化物酶体增殖剂活化受体γ）的活化的材料。解决方案：PPARγ活性抑制剂包括作为活性成分的一种或多种，选自包含木犀草素，槲皮素，紫苏提取物，生物素和菊粉。

3. 发明专利

JP2013036797A Method for searching differentiated maturity inhibitor for fat cell and/or fat accumulation inhibitor 有权
标题翻译：搜索FAT细胞和/或脂肪蓄积抑制剂的差异成熟抑制剂的方法
公开(公告)号：JP2013036797A
公开(公告)日：2013-02-21
申请号：JP2011171659
申请日：2011-08-05
申请人： Kao Corp , 花王株式会社
发明人： URANO SATOMI , MORI SHINOBU , MURASE TAKATOSHI
IPC分类号： G01N33/50 , A61K45/00 , A61P3/06 , C07K14/78 , C12Q1/02 , C12Q1/68 , G01N33/15
摘要： PROBLEM TO BE SOLVED: To provide a method for searching a differentiated maturity inhibitor for fat cells, or a fat accumulation inhibitor being effective on systematic or local body fat reduction.SOLUTION: The method for searching a differentiated maturity inhibitor for fat cells and/or a fat accumulation inhibitor is characterized in evaluating a laminin signal inhibition activity by a test substance in the fat cell. The laminin signal inhibition activity may be an activity for inhibiting the bond of laminin and laminin receptor, the laminin signal inhibition activity may be an activity for inhibiting the expression of laminin and laminin receptor, or the laminin signal inhibition activity may be an activity for inhibiting intracellular signal transduction caused by the laminin.
摘要翻译：要解决的问题：提供一种用于搜索脂肪细胞的分化成熟抑制剂的方法，或对系统或局部体内脂肪减少有效的脂肪蓄积抑制剂。解决方案：用于搜索脂肪细胞和/或脂肪蓄积抑制剂的分化成熟抑制剂的方法的特征在于通过脂肪细胞中的测试物质评价层粘连蛋白信号抑制活性。层粘连蛋白信号抑制活性可以是抑制层粘连蛋白和层粘连蛋白受体结合的活性，层粘连蛋白信号抑制活性可以是抑制层粘连蛋白和层粘连蛋白受体表达的活性，或者层粘连蛋白信号抑制活性可以是抑制由层粘连蛋白引起的细胞内信号转导。版权所有（C）2013，JPO＆INPIT

4. 发明专利

JP2012031135A Prevention or improving agent for fructose-induced disease 审中-公开
标题翻译：预防或改善溃疡性疾病的药物
公开(公告)号：JP2012031135A
公开(公告)日：2012-02-16
申请号：JP2011099206
申请日：2011-04-27
申请人： Kao Corp , 花王株式会社
发明人： MORI TAKUYA , KONDO HIDEHIKO , MURASE TAKATOSHI
IPC分类号： A61K31/685 , A61K31/683 , A61K36/00 , A61K36/48 , A61P3/06 , A61P3/10 , A61P43/00 , C12N15/09 , C12Q1/68
摘要： PROBLEM TO BE SOLVED: To provide a pharmaceutical drug or the like for prevention or improvement of diseases such as insulin resistance, fatty liver, and hyperlipemia induced by fructose ingestion, or to provide a material that can use for the pharmaceutical drug and food.SOLUTION: The preventing/improving agent for a fructose-induced disease contains a phospholipid as an active ingredient.
摘要翻译：要解决的问题：提供用于预防或改善由果糖摄取引起的胰岛素抵抗，脂肪肝和高脂血症等疾病的药物等，或提供可用于药物的材料和餐饮。解决方案：果糖诱导的疾病的预防/改善剂含有磷脂作为活性成分。版权所有（C）2012，JPO＆INPIT

5. 发明专利

JP2011037720A Dgat inhibitor 审中-公开
标题翻译： DGAT抑制剂
公开(公告)号：JP2011037720A
公开(公告)日：2011-02-24
申请号：JP2009183644
申请日：2009-08-06
申请人： Kao Corp , 花王株式会社
发明人： HASHIZUME KOJIRO , KONDO HIDEHIKO , MURASE TAKATOSHI
IPC分类号： A61K36/73 , A61K31/7024 , A61K36/00 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/50 , A61P43/00
摘要： PROBLEM TO BE SOLVED: To provide a DGAT inhibitor and a TG synthesis-suppressing agent. SOLUTION: The DGAT inhibitor and the TG synthesis-suppressing agent comprise raspberry or an extract thereof as an effective ingredient. Preferably, the DGAT inhibitor comprises the extract extracted with an organic solvent. COPYRIGHT: (C)2011,JPO&INPIT
摘要翻译：要解决的问题：提供DGAT抑制剂和TG合成抑制剂。解决方案：DGAT抑制剂和TG合成抑制剂包括覆盆子或其提取物作为有效成分。优选地，DGAT抑制剂包含用有机溶剂萃取的提取物。版权所有（C）2011，JPO＆INPIT

6. 发明专利

JP2010053138A Obesity-preventing/improving agent 审中-公开
标题翻译：防止/改善药剂
公开(公告)号：JP2010053138A
公开(公告)日：2010-03-11
申请号：JP2009273958
申请日：2009-12-01
申请人： Kao Corp , 花王株式会社
发明人： SHIMOTOYOTOME REI , SUZUKI JUNKO , YAJIMA NORIYUKI , MURASE TAKATOSHI , TOKIMITSU ICHIRO
IPC分类号： A61K31/718 , A23L1/30 , A23L1/307 , A61P3/04 , A61P3/06 , A61P3/10 , C08B31/08
摘要： PROBLEM TO BE SOLVED: To provide a material for an obesity-preventing/improving agent exhibiting the effects of preventing and improving onset of various lifestyle-related diseases such as hyperlipemia, and also for materials of foods, medicinal products and the like, having high safety and wide application and scarcely impairing texture. SOLUTION: The invention relates to an obesity-preventing/improving agent comprising a hydroxypropylated starch as an active ingredient. There is disclosed the use of the hydroxypropylated starch for obesity prevention and improvement (excluding the medical use for humans). COPYRIGHT: (C)2010,JPO&INPIT
摘要翻译：待解决的问题：提供一种具有预防和改善各种生活方式相关疾病如高脂血症的发作的效果的肥胖预防/改善剂的材料，以及用于食品，药品等的材料具有安全性高，应用广泛，几乎不损伤纹理。解决方案：本发明涉及包含羟丙基淀粉作为活性成分的肥胖症预防/改善剂。公开了用于预防和改善肥胖的羟丙基淀粉的用途（不包括人的医疗用途）。版权所有（C）2010，JPO＆INPIT

7. 发明专利

JP2010047606A Constipation dissolving agent 审中-公开
标题翻译：组合解散剂
公开(公告)号：JP2010047606A
公开(公告)日：2010-03-04
申请号：JP2009267775
申请日：2009-11-25
申请人： Kao Corp , 花王株式会社
发明人： SHIMOTOYOTOME REI , YAJIMA NORIYUKI , YAMAMOTO NAOKI , MURASE TAKATOSHI , TOKIMITSU ICHIRO
IPC分类号： A61K31/718 , A23L1/30 , A61P1/00 , A61P1/04 , A61P1/10 , A61P35/00 , C08B31/12
摘要： PROBLEM TO BE SOLVED: To provide materials for foods, medicines, etc., which exert improving effects for constipation, intestinal environment, etc., are highly safe and widely applicable, and do not spoil the texture. SOLUTION: A constipation dissolution agent, an agent for improving intestinal environment, an enhancer of intestinal mucus production, and an enhancer of production of intestinal short chain fatty acids have an effective component of hydroxypropylated starch. COPYRIGHT: (C)2010,JPO&INPIT
摘要翻译：要解决的问题：为便秘，肠道环境等提供改善效果的食品，药品等提供材料是高度安全且广泛适用的，不会破坏质地。解决方案：便秘溶解剂，肠环境改善剂，肠粘液生成增强剂和生产肠道短链脂肪酸的增强剂具有羟丙基淀粉的有效成分。版权所有（C）2010，JPO＆INPIT

8. 发明专利

JP2008120729A Farnesoid x receptor (fxr) activator 审中-公开
标题翻译： FARNESOID X受体（FXR）激活剂
公开(公告)号：JP2008120729A
公开(公告)日：2008-05-29
申请号：JP2006306238
申请日：2006-11-13
申请人： Kao Corp , Univ Of Tokyo , 国立大学法人東京大学 , 花王株式会社
发明人： TAKAHASHI YOSHISHIRO , KONDO HIDEHIKO , MURASE TAKATOSHI , SATO RYUICHIRO , KANAYAMA TOMOHIKO
IPC分类号： A61K31/37 , A61K8/49 , A61P1/16 , A61P1/18 , A61P3/06 , A61P3/10 , A61P17/16 , A61Q19/00 , C07D493/04 , C12N15/09
摘要： PROBLEM TO BE SOLVED: To provide an FXR activator which is high in safety, has an excellent FXR-activating action, and is useful as a medicine, a quasi-drug, a cosmetic, a food or the like. SOLUTION: This farnesoid X receptor (FXR) activator is characterized by containing coumestrol as an active ingredient. A lipid metabolism regulator is characterized by containing coumestrol as an active ingredient. A carbohydrate metabolism regulator is characterized by containing coumestrol as an active ingredient. COPYRIGHT: (C)2008,JPO&INPIT
摘要翻译：要解决的问题：提供安全性高的FXR活化剂，具有优异的FXR活化作用，可用作药物，准药物，化妆品，食品等。解决方案：该法尼醇X受体（FXR）激活剂的特征在于含有雌孕酮作为活性成分。脂质代谢调节剂的特征在于含有雌孕酮作为活性成分。碳水化合物代谢调节剂的特征在于含有洋甘菊作为活性成分。版权所有（C）2008，JPO＆INPIT

9. 发明专利

JP2008074793A PPARγ EXPRESSION INHIBITOR 审中-公开
标题翻译： PPARgamma表达抑制剂
公开(公告)号：JP2008074793A
公开(公告)日：2008-04-03
申请号：JP2006257960
申请日：2006-09-22
申请人： Kao Corp , 花王株式会社
发明人： MORI TAKUYA , HASHIZUME KOJIRO , KONDO HIDEHIKO , SHIBUYA YUSUKE , MURASE TAKATOSHI
IPC分类号： A61K31/661 , A61P17/00 , A61P17/10 , A61P43/00
摘要： PROBLEM TO BE SOLVED: To provide a PPARγ expression inhibitor highly safe and useful as an ingredient in pharmaceuticals or foods or the like for preventing and ameliorating dermatoses or dermal troubles involving sebum lipid abnormalities such as pimple.
SOLUTION: The PPARγ expression inhibitor comprises phospholipids as active ingredient, wherein it is preferable that the phospholipids be lysophospholipids.
COPYRIGHT: (C)2008,JPO&INPIT

10. 发明专利

JP2008013473A Muscle hypofunction inhibitor 审中-公开
标题翻译：肌肉超氧化物抑制剂
公开(公告)号：JP2008013473A
公开(公告)日：2008-01-24
申请号：JP2006185466
申请日：2006-07-05
申请人： Kao Corp , 花王株式会社
发明人： OTA NOBUYASU , MURASE TAKATOSHI
IPC分类号： A61K31/353 , A23L1/30 , A61K36/00 , A61K36/18 , A61P21/00 , A61P43/00
摘要： PROBLEM TO BE SOLVED: To provide a medicine and a food and drink, having excellent actions of suppressing amyotrophy, suppressing brawn hypofunction accompanied thereby and suppressing bedridden state caused by exercise ability decrease, and excellent in safety. SOLUTION: An amyotrophy inhibitor and a brawn hypofunction inhibitor, comprising catechin as an active ingredient is provided. And the above-mentioned myoatrophy inhibitor, which amyotrophy is disuse amyotrophy or sarcopenia, is provided. COPYRIGHT: (C)2008,JPO&INPIT

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式